Recalls Warnings

Here are your up-to-date news results!
Clicking the title of the article will give you the original publication.
You can share an article quickly with colleagues via Twitter and LinkedIn!


The J. M. Smucker Company Issues Voluntary Recall of  Specific Lots of Special Kitty® Wet, Canned Cat Food Due to Health Concerns
Published: 5 Dec 2019 | 23:20 UTC

The J. M. Smucker Company today announced a voluntary recall of specific lots of Special Kitty® wet, canned cat food due to health concerns potentially associated with ingredients believed to not meet the Company’s quality and safety standards.

Nassau Candy Distributors Issues Allergy Alert on Undeclared Milk Allergen in Nancy Adams, Dark Chocolate Graham Crackers
Published: 5 Dec 2019 | 16:53 UTC

Nassau Candy Distributors of Hicksville, NY is recalling two lots of 7.5 OZ (212g) Nancy Adams, Dark Chocolate Graham Crackers because they may contain undeclared milk allergens.

Natus gold cup electrodes and snap electrode leads – risk of electric shock
Published: 5 Dec 2019 | 12:28 UTC

Manufactured by Natus - GN Otometrics A/S: an exposed conductor may cause an electric shock to the user or patient.

Class 2 Medicines recall: Ranitidine 150mg Film-Coated Tablets, PL 20075/0063, Ranitidine 300mg Film-Coated Tablets, PL 20075/0064 (EL(19)A/40)
Published: 5 Dec 2019 | 11:30 UTC

Accord Healthcare are recalling all unexpired stock of the below products from pharmacies and retail stores as a precautionary measure.

EpiPen Jr
Published: 5 Dec 2019 | 7:00 UTC

Update on shortage

Kulchaya Sheaya Lender capsules
Published: 5 Dec 2019 | 6:30 UTC

Kulchaya Sheaya Lender capsules pose a serious risk to your health and should not be taken

Spectra Optia apheresis: anticoagulant bags used with ‘Correct Connect’ connectors – risk of unbroken ‘frangible’ connector during use (MDA/2019/041)
Published: 4 Dec 2019 | 12:02 UTC

Manufactured by Terumo BCT – inadequately broken anticoagulant ‘frangible’ may lead to clotting and inadequate therapy during apheresis procedures.

Dole Fresh Vegetables Announces Precautionary Limited Recall of Colorful Coleslaw
Published: 4 Dec 2019 | 2:05 UTC

Dole Fresh Vegetables, Inc. is voluntarily recalling a limited number of cases of Colorful Coleslaw.

UPDATE: Increased Rate of Mortality in Patients Receiving Abiomed Impella RP System - Letter to Health Care Providers
Published: 2 Dec 2019 | 5:00 UTC

The FDA is providing the most recent, interim post-approval study results for Abiomed's Impella RP System.

Sheaya Herbs tablets by Kulchaya
Published: 29 Nov 2019 | 5:00 UTC

Sheaya Herbs tablets by Kulchaya pose a serious risk to your health and should not be taken

B. Braun Medical Inc. Issues Voluntary Nationwide Recall of Twenty-Two (22) Lots of Blood Administration Sets, Due to Potential for Leakage at the Joint Between the Blood Filters and Tubing
Published: 26 Nov 2019 | 5:00 UTC

B. Braun Medical Inc. [B. Braun] initiated a voluntary recall of twenty-two (22) lots of Blood Administration Sets. B. Braun identified through complaints and internal discrepancies the potential for leakage at the joint between the blood filters and tubing of these blood administration sets.

Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP, 150mg and 300mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
Published: 22 Nov 2019 | 5:00 UTC

Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey is voluntarily recalling Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL to the consumer level. A listing of the recalled lots is identified below.
Ranitidine Tablets, USP, 150 mg and 300 mg

Yellow fever vaccine: stronger precautions in people with weakened immunity and in those aged 60 years or older
Published: 21 Nov 2019 | 14:57 UTC

The Commission on Human Medicines has issued a series of recommendations to strengthen measures to minimise risk with the yellow fever vaccine (Stamaril) following very rare fatal reactions.

Carfilzomib (Kyprolis▼): risk of reactivation of hepatitis B virus
Published: 21 Nov 2019 | 14:57 UTC

Establish hepatitis B status before initiating carfilzomib and in patients with unknown hepatitis B virus serology who are already being treated with carfilzomib.

Letters and drug alerts sent to healthcare professionals in October 2019
Published: 21 Nov 2019 | 14:56 UTC

Letters were sent about quadrivalent influenza vaccine, fentanyl ampoules, and Volibris (ambrisentan), and a number of pharmacy-level recalls were issued for ranitidine-containing products.

Withdrawn application: Luxceptar, viable T-cells, Date of withdrawal: 06/11/2019, Initial authorisation
Published: 15 Nov 2019 | 11:00 UTC

Withdrawn application: Luxceptar, viable T-cells, Date of withdrawal: 06/11/2019, Initial authorisation

Withdrawn application: Opsumit, macitentan, Date of withdrawal: 08/11/2019, Post-authorisation
Published: 15 Nov 2019 | 11:00 UTC

Withdrawn application: Opsumit, macitentan, Date of withdrawal: 08/11/2019, Post-authorisation

Withdrawn application: Linhaliq, ciprofloxacin, Date of withdrawal: 29/10/2019, Initial authorisation
Published: 15 Nov 2019 | 11:00 UTC

Withdrawn application: Linhaliq, ciprofloxacin, Date of withdrawal: 29/10/2019, Initial authorisation



Please note that GR Consulting can not alter or influence the messages displayed, nor is it responsible for its content. If needed or desired, please refer to the original message and/or its originator.